Transplantation of allogenic cells in the therapy of patients with dilated cardiomyopathy

被引：9

作者：

Kirillov, A. M. ^{[1
]}

Fatkhudinov, T. Kh. ^{[1
]}

Dyachkov, A. V. ^{[1
]}

Koroteev, A. V. ^{[1
]}

Goldshtein, D. V. ^{[1
]}

Bochkov, N. P. ^{[1
]}

机构：

[1] ReMeTeks Co, Russian Acad Sci, B V Petrovskii Russian Res Surg Ctr, Moscow, Russia

来源：

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2007年 / 144卷 / 04期

关键词：

skeletal myoblasts; multipotent stromal cells; allogenic transplantation; dilated cardiomyopathy;

D O I：

10.1007/s10517-007-0392-4

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

We carried out a pilot study on intracoronary transplantation of prenatal allogenic skeletal myoblasts and multipotent bone marrow stromal cells to patients with dilated cardiomyopathy. Intracoronary transplantation of allogenic cells is a feasible and safe procedure: there were no life-threatening rhythm and conduction disturbances, symptoms of hemodynamic instability, and thromboembolic complications. Positive clinical effect of cell transplantation persisted for 6 months and consisted in decreased content of brain natriuretic peptide and improved tolerance to physical exercises. We observed no reliable dynamics of the major echocardiographic parameters and their correlations with patient's status.

引用

页码：635 / 639

页数：5

共 50 条

[41] Trimetazidine therapy in patients with dilated cardiomyopathy and congestive heart failure
Al-Shawabkeh, N.
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S316 - S316
[42] Safety and Efficiency of Transplantation of Allogenic Multipotent Stromal Cells in Surgical Treatment of Dilatated Cardiomyopathy
Fatkhutdinov, T. Kh.
D'yachkov, A. V.
Koroteyev, A. V.
Goldstein, D. V.
Bochkov, N. P.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 149 (01) : 119 - 124
[43] Safety and Efficiency of Transplantation of Allogenic Multipotent Stromal Cells in Surgical Treatment of Dilatated Cardiomyopathy
T. Kh. Fatkhutdinov
A. V. D’yachkov
A. V. Koroteyev
D. V. Goldstein
N. P. Bochkov
Bulletin of Experimental Biology and Medicine, 2010, 149 : 119 - 124
[44] Clinical trial of growth factor therapy for patients with end-stage dilated cardiomyopathy on heart transplantation list
Komamura, K
Hanatani, A
Yamagishi, M
Mano, A
Nakatani, T
Kitamura, S
Miyatake, K
Kitakaze, M
JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S264 - S264
[45] Smooth muscle cells transplantation is better than heart cells transplantation for improvement of heart function in dilated cardiomyopathy
Yoo, KJ
Li, RK
Weisel, RD
Mickle, DAG
Tomita, S
Ohno, N
Fujii, T
YONSEI MEDICAL JOURNAL, 2002, 43 (03) : 296 - 303
[46] THE FREQUENCY OF FAMILIAL DILATED CARDIOMYOPATHY IN A SERIES OF PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY
MICHELS, VV
MOLL, PP
MILLER, FA
TAJIK, AJ
CHU, JS
DRISCOLL, DJ
BURNETT, JC
RODEHEFFER, RJ
CHESEBRO, JH
TAZELAAR, HD
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (02): : 77 - 82
[47] From allogenic transplantation to precision immune therapy: the role of effector cells
Rossi, Jean-Francois
LEUKEMIA RESEARCH, 2018, 73 : S12 - S12
[48] Defective Circulating Regulatory B Cells in Patients with Dilated Cardiomyopathy
Jiao, Jiao
Lu, Yu-Zhi
Xia, Ni
Wang, Yi-Qiu
Tang, Ting-Ting
Nie, Shao-Fang
Lv, Bing-Jie
Wang, Ke-Jing
Wen, Shuang
Li, Jing-Yong
Zhou, Xing-Di
Liao, Yu-Hua
Cheng, Xiang
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 46 (01) : 23 - 35
[49] The prevalence of Th17 cells in patients with dilated cardiomyopathy
An Yi
Li Jian
Hu Xiaojing
Xin Hui
CLINICAL AND INVESTIGATIVE MEDICINE, 2009, 32 (02): : E144 - E150
[50] Intracoronary Transplantation of CD34+ Cells Is Associated With Improved Myocardial Perfusion in Patients With Nonischemic Dilated Cardiomyopathy
Lezaic, Luka
Socan, Aljaz
Poglajen, Gregor
Peitl, Petra Kolenc
Sever, Matjaz
Cukjati, Marko
Cernelc, Peter
Wu, Joseph C.
Haddad, Francois
Vrtovec, Bojan
JOURNAL OF CARDIAC FAILURE, 2015, 21 (02) : 145 - 152

← 1 2 3 4 5 →